22 January 2026 · 10 min read

503A vs 503B: What Clinics Need to Know

Learn the key differences between 503A and 503B pharmacies, FDA oversight, office-use rules, and how clinics source compliant medications at scale.

Compounding pharmacies in the United States operate under two distinct regulatory frameworks: 503A and 503B. Understanding these categories is essential for healthcare clinics that source medications, biologics, and regenerative compounds.

503A pharmacies are state-licensed facilities that prepare patient-specific medications under individual prescriptions. They follow USP standards and state pharmacy law. 503B outsourcing facilities are FDA-registered and operate under cGMP for bulk sterile compounding—often without patient-specific prescriptions—making them ideal for office-use inventory.

FDA oversight differs significantly. 503A facilities are primarily regulated by state boards of pharmacy. 503B facilities undergo federal FDA registration and inspection and must comply with Drug Quality and Security Act (DQSA) requirements.

Clinics sourcing at scale should evaluate their needs: personalized formulations typically come from 503A; high-volume office-use products often come from 503B. ExaVeyra Sciences partners with both types to provide flexible, compliant access for healthcare providers.

Frequently Asked Questions

What is the difference between 503A and 503B pharmacies?
503A pharmacies prepare patient-specific compounded medications under state pharmacy board oversight. 503B outsourcing facilities are FDA-registered and manufacture medications in bulk under cGMP for office-use products, often without individual prescriptions.
Which type of facility should my clinic use for office-use products?
For high-volume office-use inventory (injectables, biologics, compounded preparations for in-office use), 503B facilities are typically better suited. For patient-specific formulations and personalized protocols, 503A compounding pharmacies are the appropriate choice.
Does the FDA regulate both 503A and 503B?
503A facilities are primarily regulated by state boards of pharmacy. 503B facilities undergo federal FDA registration and inspection and must comply with Drug Quality and Security Act (DQSA) requirements and Current Good Manufacturing Practices.
Can 503B facilities ship interstate?
Yes. 503B outsourcing facilities register with the FDA and can ship office-use products interstate to clinics and healthcare providers across the United States.
What should I verify when sourcing from a 503A or 503B partner?
Verify FDA registration (for 503B), state licensure (for 503A), cGMP or USP compliance, and documentation such as certificates of analysis (COA) and lot numbers. ExaVeyra partners with vetted facilities and provides full traceability.
← Back to Resources